A penny stock with a $1M market cap announcing an acquisition to expand its patent portfolio is the regulatory equivalent of a toddler buying a real estate agency with Monopoly money.
Yet, Universe Pharmaceuticals ($UPC) is roaring 300% premarket. On the other side of the tape, Farmmi ($FAMI) collapses 77% after pricing a $3.0M underwritten offering, reminding everyone of the dilution tax. Across 2,881 historical catalyst-driven gaps of 30% or more, these setups close in the red 65% of the time, with a median intraday return of -6.79%.
How many times does the circus have to run this exact play before we stop chasing the opening bell?